Stay updated on Venetoclax and Novel Agents in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.

Latest updates to the Venetoclax and Novel Agents in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record history gained a new revision entry for v3.6.3. The previous v3.6.2 entry was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedThe study history now includes a new revision entry, v3.6.2. This indicates the record was updated after the prior v3.6.0.SummaryDifference0.1%

- Check34 days agoChange DetectedA new version entry (v3.6.0) and related items were added to the study record history, including 'Check who can join', 'Find Contact Information', and 'Study Status'. The previous revision entry (v3.5.5) was removed.SummaryDifference1%

- Check41 days agoChange DetectedThe history shows a new revision label v3.5.5, replacing the previous v3.5.4, indicating a recent update to the page's underlying build.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 in the page history. This indicates a new version of the study record page.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now displays an updated ClinicalTrials.gov interface revision version (v3.5.3 instead of v3.5.2). This represents a site/version update rather than a change to the underlying study record.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Novel Agents in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Novel Agents in AML Clinical Trial page.